Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations
Volume 38 - Issue 2 - June 2023, Page 249-256
Meltem Alkan Melikoğlu

Enter the code above.